You searched for: enzymatic

The Science Behind ColdZyme – Insights from Professors
A study with athletes has shown that Enzymatica's oral spray, ColdZyme, significantly shortens the duration of upper respiratory tract infections...

Enzymatica gears up for global expansion after strong first quarter
During the first quarter, Enzymatica's net sales increased by 30,3 percent to SEK 12,3 million. Sales increased the most in Sweden and...

Enzymatica's results are published in The Journal of Physiology
Study results show that Enzymatica's ColdZyme oral spray reduces the amount of virus and inhibits its spread, leading to fewer sick days and milder...

Increased revenue in Q4 but potential for better partner sales for Enzymatica
The cold season is underway and it is also visible in Enzymatica's report for the fourth quarter, which showed increased sales compared to...

Enzymatica is recruiting an experienced marketing manager
Enzymatica strengthens its growth strategy by recruiting Anna Söderlund as Senior Director Marketing & Sales. With solid experience in...

Enzymatica provides answers to questions
SBU has recently published an evaluation that points to some difficulty in assessing the effect of ColdZyme and other...

Final study results: ColdZyme shortens illness duration and relieves symptoms
An independent study at the University of Kent shows that Enzymatica's ColdZyme oral spray reduces the duration of upper respiratory tract infections by up...

Strengthened cash flow and adjusted business model will get Enzymatica back on track
After the record numbers before the pandemic, international sales of Enzymatica's cold spray ColdZyme have slowed down. The company is...

Enzymatica's CEO comments on business development and issue
Today marks the start of the subscription period for Enzymatica's rights issue, which will finance the continued establishment of ColdZyme in the cold medicine market. At the same time, the company is launching...

MDR certification was Enzymatica's highlight during Q1
Enzymatica has recently published the Q1 report, where they highlight the MDR certification for ColdZyme as an important achievement.

Enzymatica comments on the MDR certification for ColdZyme
Enzymatica has received CE certification for ColdZyme according to the MDR, the EU's new regulation for medical devices. According to the company, this is a...

Enzymatica prepares for expansion through issuance
Enzymatica is working to establish itself in the global market for over-the-counter cold products. The company has a distribution agreement for ColdZyme in...